Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2

BACKGROUND: Amantadine is a drug that can help in the prevention of SARS-CoV-2 symptomatology, as has been demonstrated in observational clinical studies. METHODS: We searched in the PubMed database Clinical Studies of coronavirus-infected patients who have been treated with amantadine in a preventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortés-Borra, Albert, Aranda-Abreu, Gonzalo Emiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891470/
https://www.ncbi.nlm.nih.gov/pubmed/33604795
http://dx.doi.org/10.1007/s43440-021-00231-5
_version_ 1783652705237991424
author Cortés-Borra, Albert
Aranda-Abreu, Gonzalo Emiliano
author_facet Cortés-Borra, Albert
Aranda-Abreu, Gonzalo Emiliano
author_sort Cortés-Borra, Albert
collection PubMed
description BACKGROUND: Amantadine is a drug that can help in the prevention of SARS-CoV-2 symptomatology, as has been demonstrated in observational clinical studies. METHODS: We searched in the PubMed database Clinical Studies of coronavirus-infected patients who have been treated with amantadine in a preventive manner as well as patients with Parkinson’s disease. RESULTS: Four clinical studies were found in which relatives of patients with COVID-19 had been prescribed the use of amantadine in a preventive manner to avoid the symptoms caused by the coronavirus. CONCLUSION: Amantadine is a drug that can be prescribed as a prophylactic that prevents symptomatology caused by SARS-CoV-2 coronavirus.
format Online
Article
Text
id pubmed-7891470
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-78914702021-02-19 Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2 Cortés-Borra, Albert Aranda-Abreu, Gonzalo Emiliano Pharmacol Rep Short Communication BACKGROUND: Amantadine is a drug that can help in the prevention of SARS-CoV-2 symptomatology, as has been demonstrated in observational clinical studies. METHODS: We searched in the PubMed database Clinical Studies of coronavirus-infected patients who have been treated with amantadine in a preventive manner as well as patients with Parkinson’s disease. RESULTS: Four clinical studies were found in which relatives of patients with COVID-19 had been prescribed the use of amantadine in a preventive manner to avoid the symptoms caused by the coronavirus. CONCLUSION: Amantadine is a drug that can be prescribed as a prophylactic that prevents symptomatology caused by SARS-CoV-2 coronavirus. Springer International Publishing 2021-02-18 2021 /pmc/articles/PMC7891470/ /pubmed/33604795 http://dx.doi.org/10.1007/s43440-021-00231-5 Text en © Maj Institute of Pharmacology Polish Academy of Sciences 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Short Communication
Cortés-Borra, Albert
Aranda-Abreu, Gonzalo Emiliano
Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2
title Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2
title_full Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2
title_fullStr Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2
title_full_unstemmed Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2
title_short Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2
title_sort amantadine in the prevention of clinical symptoms caused by sars-cov-2
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891470/
https://www.ncbi.nlm.nih.gov/pubmed/33604795
http://dx.doi.org/10.1007/s43440-021-00231-5
work_keys_str_mv AT cortesborraalbert amantadineinthepreventionofclinicalsymptomscausedbysarscov2
AT arandaabreugonzaloemiliano amantadineinthepreventionofclinicalsymptomscausedbysarscov2

Ejemplares similares